Nuclear bioavailability of the glucocorticoid receptor in a pediatric asthma cohort with variable corticosteroid responsiveness

Pediatric Research

Volumn 78, Issue 5, 2015, Pages 505-512

  Cornejo, Salomon ^a,b   Tantisira, Kelan ^c   Raby, Benjamin A ^c   Weiss, Scott T ^c   Kaplan, Feige ^a,b,d  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; ANTIINFLAMMATORY AGENT; HYDROCORTISONE; NR3C1 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; ASTHMA; BIOAVAILABILITY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HORMONE RECEPTOR TRANSLOCATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MALE; MULTICENTER STUDY (TOPIC); NUCLEAR IMPORT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE; WESTERN BLOTTING; ACTIVE TRANSPORT; AGONISTS; B LYMPHOCYTE; CELL NUCLEUS; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; FORCED EXPIRATORY VOLUME; GENETICS; LUNG; METABOLISM; PATHOPHYSIOLOGY; TIME FACTOR; TRANSFORMED CELL LINE; TREATMENT OUTCOME;

ACTIVE TRANSPORT, CELL NUCLEUS; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ASTHMA; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; DRUG RESISTANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROCORTISONE; LUNG; MALE; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME;

EID: 84946097591     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2015.148     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention/National Center of Health Statistics and the American Lung Association. Asthma & Children Fact Sheet, 2014. http://www.lung.org/lung-disease/asthma/resources/factsand-figures/asthma-children-fact-sheet.html
2. Public Health Agency of Canada. Life and Breath: Respiratory Disease in Canada, 2007. http://www.phac-aspc.gc.ca/publicat/2007/lbrdc-vsmrc/asthma-asthme-eng.php#t51
3. Global Initiative for Asthma (GINA): The Global Strategy for Asthma Management and Prevention, 2014. http://www.ginasthma.org
4. Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006; 148: 245-54
5. Szefler SJ, Martin RJ, King TS, et al. Asthma Clinical Research Network of the National Heart Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410-8
6. Chan MT, Leung DY, Szefler SJ, Spahn JD. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 1998; 101: 594-601
7. Ito K, Mercado N. Therapeutic targets for new therapy for corticosteroid refractory asthma. Expert Opin Ther Targets 2009; 13: 1053-67
8. Tao T, Lan J, Lukacs GL, Haché RJ, Kaplan F. Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. Am J Respir Cell Mol Biol 2006; 35: 668-80
9. Pujols L, Mullol J, Torrego A, Picado C. Glucocorticoid receptors in human airways. Allergy 2004; 59: 1042-52
10. Sher ER, Leung DY, Surs W, et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93: 33-9
11. Matthews JG, Ito K, Barnes PJ, Adcock IM. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 2004; 113: 1100-8
12. Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 2006; 173: 607-16
13. Trevor JL, Deshane JS. Refractory asthma: mechanisms, targets, and therapy. Allergy 2014; 69: 817-27
14. Torrego A, Pujols L, Roca-Ferrer J, Mullol J, Xaubet A, Picado C. Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity. Am J Respir Crit Care Med 2004; 170: 420-5
15. Miller GE, Chen E. Life stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthma. Proc Natl Acad Sci USA 2006; 103: 5496-501
16. Gagliardo R, Chanez P, Vignola AM, et al. Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med 2000; 162: 7-13
17. Pujols L, Mullol J, Pérez M, et al. Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Respir Cell Mol Biol 2001; 24: 49-57
18. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987; 1: 68-74
19. Freedman ND, Yamamoto KR. Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell 2004; 15: 2276-86
20. Burnstein KL, Jewell CM, Sar M, Cidlowski JA. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormoneinducible receptor messenger RNA down-regulation through multiple mechanisms. Mol Endocrinol 1994; 8: 1764-73
21. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 1997; 272: 9287-93
22. Wallace AD, Cao Y, Chandramouleeswaran S, Cidlowski JA. Lysine 419 targets human glucocorticoid receptor for proteasomal degradation. Steroids 2010; 75: 1016-23
23. Wallace AD, Cidlowski JA. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 2001; 276: 42714-21
24. Chauhan D, Hideshima T, Mitsiades C, Richardson P, Anderson KC. Proteasome inhibitor therapy in multiple myeloma. Mol Cancer Ther 2005; 4: 686-92
25. Deroo BJ, Rentsch c, Sampath S, Young J, DeFranco DB, Archer TK. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 2002; 22: 4113-23
26. The Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): Design, rationale, and methods. Controlled Clinical Trials 1999; 20: 91-120
27. The Childhood Asthma Management Program Research Group. Longterm effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054-63
28. Carpe N, Mandeville I, Ribeiro L, et al. Genetic influences on asthma susceptibility in the developing lung. Am J Respir Cell Mol Biol 2010; 43: 720-30